VTRSViatris Inc.

$16B

FY 2010 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$5.5B+7.0% YoY

Gross Profit

$2.2B40.7% margin

Operating Income

$722M13.2% margin

Net Income

$345M6.3% margin

EPS (Diluted)

$0.68

Cash Flow

Operating Cash Flow

$931M

Free Cash Flow

$739M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$11.5B

Total Liabilities

$7.9B

Stockholders' Equity

$3.6B

Cash & Equivalents

$686M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.5B	$5.1B	+7.0%
Gross Profit	$2.2B	$2.1B	+6.9%
Operating Income	$722M	$523M	+37.9%
Net Income	$345M	$233M	+48.4%

VTRS FY 2010 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena